Nr. 1, 2007 - Romanian Journal of Cardiology

Andreea Catarina PopescuRemodelarea ventriculară stângă în stenoza aorticăBIBLIOGRAFIE1. Grossman W, Jones D, Mc Laurin LP. Wall stress and patterns ofhypertrophy in the human left ventricle. J Clin Invest 1975;56:56–64.2. Meerson FZ. Compensatory hyperfunction of the heart and cardiacinsufficiency. Circ Res 1962;10:250–8.3. Gunther S, Grossman W. Determinants of ventricular function inpressure overload hypertrophy in man. Circulation 1979;59:679–88.4. Carabello BA, Green LH, Grossman W, si colab. Hemodynamic determinantsof prognosis of aortic valve replacement in critical aorticstenosis and advanced congestive heart failure.Circulation 1980;62:42–8.5. Villari B, Vassalli G, Schneider J, si colab. Age dependency of leftventri cular diastolic function in pressure overload hypertrophy. J AmColl Cardiol 1997;29:181–6.6. Aurigemma GP, Silver KH, McLaughlin M, si colab. Impact of chambergeometry and gender on left ventricular systolic function in patients>60 years of age with aortic stenosis. Am J Cardiol 1994;74:794–8.7. Villari B, Campbell SE, Schneider J, si colab. Sex-dependent differencesin left ventricular function and structure in chronic pressure overload.Eur Heart J 1995;16:1410–9.8. McKenney PA, Apstein CS, Mendes LA, si colab. Immediate effect ofaortic valve replacement for aortic stenosis on left ventricular diastolicchamber stiffness. Am J Cardiol 1999;84:914–8.9. Vekshtein VI, Alexander RW, Yeung AC, si colab. Coronary atherosclerosisis associated with left ventricular dysfunction and dilatation inaortic stenosis. Circulation 1990;82:2068–74.10. Marcus ML, Donald BD, Hiratzka LF, si colab. Decreased coronaryreserve. A mechanism for angina pectoris in patients with aortic stenosisand normal coronary arteries. N Engl J Med 1982;307:1362–7.11. Villari B, Hess OM, Moccetti D, si colab. Effect of progression of leftventricular hypertrophy on coronary artery dimensions in aorticvalve disease. J Am Coll Cardiol 1992;20:1073–9.12. Dellsperger KC, Marcus ML. Effects of left ventricular hypertrophyon the coronary circulation. Am J Cardiol 1990;65:1504–10.13. Kenny A, Wisbey CR, Shapiro LM. Profiles of coronary blood flowin patients with aortic stenosis and the effect of valve replacement: atransthoracic echocardiographic study. Br Heart J 1994;71:57–62.14. Hongo M, Goto T, Watanabe N, si colab. Relation of phasic coronaryflow velocity profile to clinical and hemodynamic characteristics ofpatients with aortic valve disease. Circulation 1993;88:953–60.15. Chambers J, Takeda S, Rimington H, si colab. Determinants of left ventricularmass in aortic stenosis. J Heart Valve Disease 2004;13:873–80.16. Lund O, Erlendsen M, Dorup I, si colab. Predictable changes in leftventricular mass and function during ten years after valve replacementfor aortic stenosis. J Heart Valve Dis 2004;13:357–68.17. Seiler C, Jenni R. Severe aortic stenosis without left ventricularhypertrophy: prevalence, predictors, and short-term follow-up afteraortic valve replacement. Heart 1996;76:250–5.18. Kupari M, Turto H, Lommi J. Left ventricular hypertrophy in aorticvalve stenosis: preventive or promotive of systolic dysfunction andheart failure? Eur Heart J 2005;26: 1790–96.19. Buermans HPJ, Paulus WJ. Iconoclasts topple adaptive myocardialhypertrophy in aortic stenosis. Eur Heart J 2005;26:1697–9.20. Quere JP, Monin JL, Levy F, si colab. Influence of preoperative leftventricular contractile reserve on postoperative ejection fraction inlow-gradient aortic stenosis. Circulation 2006;113:1738–44.21. Vaquette B, Corbineau H, Laurent M, si colab. Valve replacement inpatients with critical aortic stenosis and depressed left ventricularfunction: predictors of operative risk, left ventricular functionrecovery, and long term outcome. Heart 2005;91;1324-9.22. Houser SR, Margulies KB. Is depressed myocyte contractility centrallyinvolved in heart failure? Circ Res 2003;92:350-8.23. Takeda S, Rimington H, Smeeton N, si colab. Long axis excursion inaortic stenosis. Heart 2001;86:52–6.24. Tongue AG, Dumesnil JG, Laforest I, si colab. Left ventricularlongitudinal shortening in patients with aortic stenosis: relationshipwith symptomatic status. J Heart Valve Dis 2003;12:142–9.25. Villari B, Vassalli G, Scott Monrad E, si colab. Normalization ofdiastolic dysfunction in aortic stenosis late after valve replacement.Circulation 1995;91:2353-8.Revista Română de CardiologieVol. XXII, Nr. 1, 200726. McKenney PA, Apstein CS, Mendes LA, si colab. Immediate effect ofaortic valve replacement for aortic stenosis on left ventricular diastolicchamber stiffness. Am J Cardiol 1999;84:914-8.27. Gjertsson P, Caidahl K, Bech-Hanssen O. Left ventricular diastolicdysfunction late after aortic valve replacement in patients with aorticstenosis Am J Cardiol 2005;96:722-7.28. Gjertsson P, Caidahl K, Farasati M, Oden A, Bech-Hanssen O. Preoperativemoderate to severe diastolic dysfunction: a novel Doppler echocardiographiclong-term prognostic factor in patients with severeaortic stenosis. J Thorac Cardiovasc Surg 2005;129:890-6.29. Schwarz F, Kittstein D, Winkler B, Schaper J. Quantitative ultrastructureof the myocardium in chronic aortic valve disease. Basic ResCardiol 1980;75:109–17.30. Lund O, Kristensen LH, Baandrup U, si colab. Myocardial structureas a determinant of pre- and postoperative ventricular function andlong-term prognosis after valve replacement for aortic stenosis. EurHeart J 1998;19:1099–108.31. Litwin SE, Katz SE, Weinberg EO, si colab. Chronic angiotensin-convertingenzyme inhibition attenuates the transition to heart failure. Serialechocardiographic-Doppler assessment of left lentricular geometryand function in rats with pressure-overload hypertrophy. Circulation1995;91:2642-54.32. Galiuto L, Lotrionte M, Crea F, si colab. Impaired coronary andmyocardial flow in severe aortic stenosis is associated with increasedapoptosis. Heart 2006;92:208–212.33. Hein S, Arnon E, Kostin S, si colab. Progression from compensatedhypertrophy to failure in the pressure-overloaded human heart:structural deterioration and compensatory mechanisms. Circulation2003;107:984–91.34. Ding B, Price RL, Goldsmith EC, si colab. Left ventricular hypertrophyin ascending aortic stenosis mice: anoikis and the progression to earlyfailure. Circulation 2000;101:2854–6235. Esposito G, Rapacciuolo A, Prasad SVN, si colab. Genetic alterationsthat inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunctiondespite increased wall stress. Circulation 2002;105:85–92.36. Buermans HPJ, Redout EM, Schiel AE, si colab. Micro-array analysisreveals pivotal divergent mRNA expression profiles early in thedevelop ment of either compensated ventricular hypertrophy or heartfailure. Physiol Genomics 2005;21:314-23.37. Rothermel BA, Berenji K, Tannous P, si colab. Differential activationof stress-response signaling in load-induced cardiac hypertrophy andfailure. Physiol Genomics 2005; 23:18-27.38. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. Controversies inventricular remodelling. Lancet 2006;367:356-67.39. Baines CP, Molkentin JD. Stress signaling pathways that modulatecardiac myocyte apoptosis. J Mol Cell Cardiol 2005;38:47–62.40. Kishimoto I, Rossi K, Garbers DL. A genetic model provides evidencethat the receptor for atrial natriuretic peptide (guanylylcyclase-A)inhibits cardiac ventricular myocyte hypertrophy. Proc Nat Acad SciUSA 2001;98:2703–6.41. Heymans S, Schroen B, Vermeersch P, si colab. Increased cardiac expressionof tissue inhibitor of metalloproteinase-1 and tissue inhi bitor ofmetalloproteinase-2 is related to cardiac fibrosis and dysfunction inthe chronic pressure-overloaded human heart. Circulation 2005;112:1136–44.42. Polyakova V, Hein S, Kostin S, Ziegelhoeffer T, Schaper J. Matrixmetalloproteinases and their tissue inhibitors in pressure overloadedhuman myocardium during heart failure progression. J Am CollCardiol 2004;44:1609–18.43. Siwik DA, Pagano PJ, Colucci WS. Oxidative stress regulates collagensynthesis and matrix metalloproteinase activity in cardiac fibroblasts.Am J Physiol Cell Physiol 2001; 280:C53–60.44. Ruetten H, Dimmeler S, Gehring D, Ihling C, Zeiher AM. Concentricleft ventricular remodeling in endothelial nitric oxide synthaseknockout mice by chronic pressure overload. Cardiovasc Res 2005;66:444–53.45. Banfi C, Cavalca V, Veglia F, si colab. Neurohormonal activation isassociated with increased levels of plasma matrix metalloproteinase-2in human heart failure. Eur Heart J 2005;26:481–8.46. Reiken S, Wehrens XHT, Vest JA, si colab. β-blockers restore calciumrelease channel function and improve cardiac muscle performance inhuman heart failure. Circulation 2003;107:2459–66.